Haleon said its organic revenue would rise between 4%-6% this year, as the consumer healthcare company reported its first full-year results since it was spun off from GSK in 2022.

Analysts on average expect organic revenue to grow by 4.5%, according to a company-compiled consensus.

(Reporting by Eva Mathews in Bengaluru; Editing by Subhranshu Sahu)